{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:54:52Z","timestamp":1771977292020,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFC1309000"],"award-info":[{"award-number":["2017YFC1309000"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2018A030313663"],"award-info":[{"award-number":["2018A030313663"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2018001"],"award-info":[{"award-number":["A2018001"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00428-020-02776-x","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T22:02:46Z","timestamp":1587420166000},"page":"873-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["CD20-positive extranodal NK\/T cell lymphoma: clinicopathologic and prognostic features"],"prefix":"10.1007","volume":"477","author":[{"given":"Yuhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"2776_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10637-016-0349-4","volume":"34","author":"Y Safdari","year":"2016","unstructured":"Safdari Y, Ahmadzadeh V, Farajnia S (2016) CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies. Investig New Drugs 34:497\u2013512","journal-title":"Investig New Drugs"},{"key":"2776_CR2","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","volume":"22","author":"MR Smith","year":"2003","unstructured":"Smith MR (2003) Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene 22:7359\u20137368","journal-title":"Oncogene"},{"key":"2776_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2559.2010.03584.x","volume":"57","author":"HS Gill","year":"2010","unstructured":"Gill HS, Lau WH, Chan AC, Leung RY, Khong PL, Leung AY, Kwong YL (2010) CD20 expression in natural killer T cell lymphoma. Histopathology 57:157\u2013159","journal-title":"Histopathology"},{"key":"2776_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1746-1596-7-133","volume":"7","author":"QP Jiang","year":"2012","unstructured":"Jiang QP, Liu SY, Yang YX, Tan XX, Peng J, Xiong ZT, Li Z (2012) CD20-positive NK\/T-cell lymphoma with indolent clinical course: report of case and review of literature. Diagn Pathol 7:133","journal-title":"Diagn Pathol"},{"key":"2776_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2340\/00015555-2576","volume":"97","author":"VG Frings","year":"2017","unstructured":"Frings VG, Roth S, Riedmiller AL, Schafer K, Goebeler M, Rosenwald A, Geissinger E, Wobser M (2017) Primary cutaneous T-cell lymphoma with aberrant expression of CD20. Acta Derm Venereol 97:534\u2013536","journal-title":"Acta Derm Venereol"},{"key":"2776_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12185-015-1841-x","volume":"102","author":"Y Kakinoki","year":"2015","unstructured":"Kakinoki Y, Hashiguchi J, Ishio T, Chiba K, Niino D, Ohshima K (2015) CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review. Int J Hematol 102:702\u2013708","journal-title":"Int J Hematol"},{"key":"2776_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.3880265","volume":"14","author":"X Yao","year":"2001","unstructured":"Yao X, Teruya-Feldstein J, Raffeld M, Sorbara L, Jaffe ES (2001) Peripheral t-cell lymphoma with aberrant expression of cd79a and cd20: a diagnostic pitfall. Mod Pathol 14:105\u2013110","journal-title":"Mod Pathol"},{"key":"2776_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/PAS.0000000000000091","volume":"37","author":"ML Jullie","year":"2013","unstructured":"Jullie ML, Carlotti M, Vivot A Jr, Beylot-Barry M, Ortonne N, Frouin E, Carlotti A, de Muret A, Balme B, Franck F, Merlio JP, Vergier B (2013) CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact. Am J Surg Pathol 37:1845\u20131854","journal-title":"Am J Surg Pathol"},{"key":"2776_CR9","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri SA (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472\u20132479","journal-title":"J Clin Oncol"},{"key":"2776_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/1066896917714325","volume":"25","author":"N Gupta","year":"2017","unstructured":"Gupta N, Nasim M, Spitzer SG, Zhang X (2017) Primary central nervous system t-cell lymphoma with aberrant expression of CD20 and CD79a: a diagnostic pitfall. Int J Surg Pathol 25:599\u2013603","journal-title":"Int J Surg Pathol"},{"key":"2776_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ajcp\/102.4.483","volume":"102","author":"L Quintanilla-Martinez","year":"1994","unstructured":"Quintanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL (1994) Cd20+ t-cell lymphoma. Neoplastic transformation of a normal t-cell subset. Am J Clin Pathol 102:483\u2013489","journal-title":"Am J Clin Pathol"},{"key":"2776_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1600-0609.2008.01058.x","volume":"80","author":"J Ando","year":"2008","unstructured":"Ando J, Sugimoto K, Ando M, Isobe Y, Sasaki M, Oshimi K (2008) Cd20-positive extranodal NK-cell lymphoma, nasal-type. Eur J Haematol 80:549\u2013550","journal-title":"Eur J Haematol"},{"key":"2776_CR13","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.4081\/rt.2009.e58","volume":"1","author":"S Kobold","year":"2009","unstructured":"Kobold S, Merz H, Tiemann M, Mahuad C, Bokemeyer C, Koop I, Fiedler W (2009) Primary NK\/T cell lymphoma nasal type of the stomach with skin involvement: a case report. Rare Tumors 1:e58","journal-title":"Rare Tumors"},{"key":"2776_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/jclinpath-2015-203188","volume":"68","author":"YH Huang","year":"2015","unstructured":"Huang YH, Huang CT, Tan SY, Chuang SS (2015) Primary gastric extranodal natural killer\/t-cell lymphoma, nasal type, with acquisition of cd20 expression in the subcutaneous relapse: report of a case with literature review. J Clin Pathol 68:943\u2013945","journal-title":"J Clin Pathol"},{"key":"2776_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/neup.12438","volume":"38","author":"D Li","year":"2018","unstructured":"Li D, Fu F, Lian L (2018) Primary central nervous system extranodal nasal-type natural killer\/t-cell lymphoma with cd20 expression. Neuropathology 38:198\u2013204","journal-title":"Neuropathology"},{"key":"2776_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/cup.12502","volume":"42","author":"YC Tsai","year":"2015","unstructured":"Tsai YC, Chen CK, Wu YH (2015) Cd20-positive nodal natural killer\/t-cell lymphoma with cutaneous involvement. J Cutan Pathol 42:639\u2013644","journal-title":"J Cutan Pathol"},{"key":"2776_CR17","first-page":"368","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th Edition","author":"JKC Chan","year":"2017","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA (2017) Extranodal NK\/T-cell lymphoma, nasal type. In: Steven H, Swerdlow EC, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th Edition. IARC, Lyon, pp 368\u2013371"},{"key":"2776_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/PAS.0000000000001210","volume":"43","author":"Y Huang","year":"2019","unstructured":"Huang Y, Shi X, Zhong P, Wang Y, Xiao H, Zhou X, Yun J (2019) De novo testicular extranodal NK\/T-cell lymphoma: a clinicopathologic study of 21 cases with review of additional 18 cases in the literature. Am J Surg Pathol 43:549\u2013558","journal-title":"Am J Surg Pathol"},{"key":"2776_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","volume":"145","author":"Y Huang","year":"2016","unstructured":"Huang Y, Xie J, Ding Y, Zhou X (2016) Extranodal natural killer\/t-cell lymphoma in children and adolescents: a report of 17 cases in China. Am J Clin Pathol 145:46\u201354","journal-title":"Am J Clin Pathol"},{"key":"2776_CR20","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"AW Langerak","year":"2012","unstructured":"Langerak AW, Groenen PJ, Bruggemann M, Beldjord K, Bellan C, Bonello L, Boone E, Carter GI, Catherwood M, Davi F, Delfau-Larue MH, Diss T, Evans PA, Gameiro P, Garcia Sanz R, Gonzalez D, Grand D, Hakansson A, Hummel M, Liu H, Lombardia L, Macintyre EA, Milner BJ, Montes-Moreno S, Schuuring E, Spaargaren M, Hodges E, van Dongen JJ (2012) EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia 26:2159\u20132171","journal-title":"Leukemia"},{"key":"2776_CR21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303","journal-title":"Genome Res"},{"key":"2776_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P, Cunningham F (2016) The Ensembl Variant Effect Predictor. Genome Biol 17:122","journal-title":"Genome Biol"},{"key":"2776_CR23","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H (2010) Annovar: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164","journal-title":"Nucleic Acids Res"},{"key":"2776_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Exome Aggregation C (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285\u2013291","journal-title":"Nature"},{"key":"2776_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"2776_CR26","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1097\/PAS.0b013e31817d7452","volume":"32","author":"A Rahemtullah","year":"2008","unstructured":"Rahemtullah A, Longtine JA, Harris NL, Dorn M, Zembowicz A, Quintanilla-Fend L, Preffer FI, Ferry JA (2008) CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 32:1593\u20131607","journal-title":"Am J Surg Pathol"},{"key":"2776_CR27","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol 29:4410\u20134416","journal-title":"J Clin Oncol"},{"key":"2776_CR28","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood-2015-04-639336","volume":"126","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhu Y, Cao JZ, Zhang YJ, Xu LM, Yuan ZY, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Li YX (2015) Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study. Blood 126:1424\u20131432","journal-title":"Blood"},{"key":"2776_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.pai.0000145130.02931.74","volume":"14","author":"RM Seliem","year":"2006","unstructured":"Seliem RM, Freeman JK, Steingart RH, Hasserjian RP (2006) Immunophenotypic changes and clinical outcome in b-cell lymphomas treated with rituximab. Appl Immunohistochem Mol Morphol 14:18\u201323","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2776_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","volume":"26","author":"B Petitjean","year":"2002","unstructured":"Petitjean B, Jardin F, Joly B, Martin-Garcia N, Tilly H, Picquenot JM, Briere J, Danel C, Mehaut S, Abd-Al-Samad I, Copie-Bergman C, Delfau-Larue MH, Gaulard P (2002) Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 26:724\u2013732","journal-title":"Am J Surg Pathol"},{"key":"2776_CR31","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0b013e31825e63a9","volume":"36","author":"JL Oliveira","year":"2012","unstructured":"Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL (2012) Clinicopathologic features of b-cell lineage neoplasms with aberrant expression of cd3: a study of 21 cases. Am J Surg Pathol 36:1364\u20131370","journal-title":"Am J Surg Pathol"},{"key":"2776_CR32","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2004-05-1845","volume":"104","author":"R Haddad","year":"2004","unstructured":"Haddad R, Guardiola P, Izac B, Thibault C, Radich J, Delezoide AL, Baillou C, Lemoine FM, Gluckman JC, Pflumio F, Canque B (2004) Molecular characterization of early human T\/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 104:3918\u20133926","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02776-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T21:21:29Z","timestamp":1666387289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2776"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02776-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board of Sun Yat-sen University Cancer Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent for the collection and publication of their medical information during the first visit to our center (The RDD number is RDDA2019001101.)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}